Top compounds associated with response to SFTPC


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.082 0.08
mRNA tivozanib CTRPv2 pan-cancer AAC -0.024 0.5
mRNA tivozanib GDSC1000 pan-cancer AAC -0.009 0.8
mRNA tosedostat CTRPv2 pan-cancer AAC -0.035 0.4
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0021 1
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.061 0.06
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.026 0.5
mRNA triptolide CTRPv2 pan-cancer AAC 0.0087 0.8
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.032 0.6
Download CSV